Tomáš Andrašina

629 total citations
52 papers, 463 citations indexed

About

Tomáš Andrašina is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomáš Andrašina has authored 52 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Surgery, 17 papers in Hepatology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomáš Andrašina's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Tomáš Andrašina is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (12 papers) and Pancreatic and Hepatic Oncology Research (10 papers). Tomáš Andrašina collaborates with scholars based in Czechia, Israel and United States. Tomáš Andrašina's co-authors include Vlastimil Válek, Jiří Pánek, Rita Golfieri, Pietro Quaretti, Tomáš Rohan, Madhava Pai, Robert C.G. Martin, Cliff Tatum, Cristina Mosconi and Nagy Habib and has published in prestigious journals such as Scientific Reports, World Journal of Gastroenterology and Annals of Surgical Oncology.

In The Last Decade

Tomáš Andrašina

44 papers receiving 452 citations

Peers

Tomáš Andrašina
Tomáš Andrašina
Citations per year, relative to Tomáš Andrašina Tomáš Andrašina (= 1×) peers Etsuji Ishida

Countries citing papers authored by Tomáš Andrašina

Since Specialization
Citations

This map shows the geographic impact of Tomáš Andrašina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Andrašina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Andrašina more than expected).

Fields of papers citing papers by Tomáš Andrašina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Andrašina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Andrašina. The network helps show where Tomáš Andrašina may publish in the future.

Co-authorship network of co-authors of Tomáš Andrašina

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Andrašina. A scholar is included among the top collaborators of Tomáš Andrašina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Andrašina. Tomáš Andrašina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rohan, Tomáš, et al.. (2025). Prognostic factors for survival in patients with advanced cholangiocarcinoma treated with percutaneous transhepatic drainage. Scientific Reports. 15(1). 2172–2172. 1 indexed citations
2.
Collettini, Federico, Tomáš Andrašina, Peter Reimer, et al.. (2024). Degradable starch microspheres transarterial chemoembolization (DSM-TACE) in patients with unresectable hepatocellular carcinoma: results from the Prospective Multicenter Observational HepaStar Trial. European Radiology. 35(7). 4132–4140. 6 indexed citations
3.
Lipový, Břetislav, Jan Křivánek, Marcela Buchtová, et al.. (2023). Primary cilia and hypoxia-associated signaling in developmental odontogenic cysts in relation to autosomal dominant polycystic kidney disease – A novel insight. Heliyon. 9(6). e17130–e17130. 2 indexed citations
4.
Rohan, Tomáš, Jaroslav Juráček, Igor Kišš, et al.. (2023). Biomarkers as prognostic and predictive factors in patients with hepatocellular carcinoma undergoing radiological oncological interventions. Klinicka onkologie. 36(2). 104–111. 1 indexed citations
5.
Rohan, Tomáš, et al.. (2022). Percutaneous Endoluminal Radiofrequency Ablation of Occluded Biliary Metal Stent in Malignancy Using Monopolar Technique: A Feasibility Study. CardioVascular and Interventional Radiology. 45(6). 873–878. 2 indexed citations
6.
Rohan, Tomáš, Tomáš Andrašina, Veronika Novotná, et al.. (2021). Experimental model of occluded biliary metal stent recanalization using irreversible electroporation via a tubular catheter. International Journal of Hyperthermia. 38(1). 393–401. 2 indexed citations
7.
Kunovský, Lumír, Petr Dítě, Petr Jabandžiev, et al.. (2021). Autoimmune Diseases of Digestive Organs—A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. Journal of Clinical Medicine. 10(24). 5796–5796. 1 indexed citations
8.
Andrašina, Tomáš, et al.. (2021). Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs. Journal of Vascular and Interventional Radiology. 32(3). 403–411. 12 indexed citations
9.
Kunovský, Lumír, Radek Kroupa, Petr Jabandžiev, et al.. (2021). Achalasia and acromegaly: Co-incidence of these diseases or a new syndrome?. Biomedical Papers. 166(2). 228–235.
10.
Andrašina, Tomáš, Michal Crha, Ladislav Stehlík, et al.. (2019). The methodology for endoluminal irreversible electroporation in porcine models. Acta Veterinaria Brno. 88(2). 201–205. 3 indexed citations
11.
Kunovský, Lumír, et al.. (2019). Triple malignancy (NET, GIST and pheochromocytoma) as a first manifestation of neurofibromatosis type-1 in an adult patient. Diagnostic Pathology. 14(1). 77–77. 8 indexed citations
12.
Kunovský, Lumír, Zdeněk Kala, Vladimír Procházka, et al.. (2018). Surgical Treatment of Ampullary Adenocarcinoma – Single Center Experience and a Review of Literature. Klinicka onkologie. 31(1). 46–52. 5 indexed citations
13.
Ovesná, Petra, et al.. (2016). Contrast-enhanced ultrasonography in the evaluation of incidental focal liver lesions: A cost-effectiveness analysis. World Journal of Gastroenterology. 22(38). 8605–8605. 32 indexed citations
14.
Mechl, Zdeněk, Zdeněk Adam, Eva Jandáková, et al.. (2015). Patient with Inoperable Pheochromocytoma. Current Oncology. 22(3). 216–219. 2 indexed citations
15.
Mizandari, Malkhaz, Madhava Pai, Vlastimil Válek, et al.. (2012). Percutaneous Intraductal Radiofrequency Ablation is a Safe Treatment for Malignant Biliary Obstruction: Feasibility and Early Results. CardioVascular and Interventional Radiology. 36(3). 814–819. 54 indexed citations
16.
Crha, Michal, Jan Hlavsa, Vladimír Procházka, et al.. (2011). Radiofrequency ablation of pancreas and optimal cooling of peripancreatic tissue in an ex-vivo porcine model. Acta Veterinaria Brno. 80(4). 407–413. 3 indexed citations
17.
Černá, Marie, Martin Köcher, Vlastimil Válek, et al.. (2011). Covered Biodegradable Stent: New Therapeutic Option for the Management of Esophageal Perforation or Anastomotic Leak. CardioVascular and Interventional Radiology. 34(6). 1267–1271. 52 indexed citations
18.
Bower, Matthew, Ken Robbins, Dana Tomalty, et al.. (2010). Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study. HPB. 12(1). 31–36. 37 indexed citations
19.
Andrašina, Tomáš, Vlastimil Válek, Jiří Pánek, et al.. (2010). Multimodal Oncological Therapy Comprising Stents, Brachytherapy, and Regional Chemotherapy for Cholangiocarcinoma. Gut and Liver. 4(Suppl.1). S82–S82. 17 indexed citations
20.
Schiffman, Suzanne, Gregory Dubel, Tomáš Andrašina, et al.. (2010). Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable Intrahepatic Cholangiocellular Carcinoma: Optimal Tolerance and Prolonged Overall Survival. Annals of Surgical Oncology. 18(2). 431–438. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026